New Brunswick Family Medicine · 200 patients
Good evening, Dr. Rivera.
6 trials fit your patients, with 4 pre-screen candidates between them. Ranked by how many of your patients could join. We pre-screened your panel against 39 open trials on Oct 11, 2026; patient records never left your practice.
Atrial Fibrillation
REGN7508
This study is researching 2 different experimental drugs called REGN7508 and REGN9933 (called "study drugs"). The study is focused on people who have atrial fibrillation, which means that the heart beats too fast and unevenly. When this happens, blood cannot move smoothly through the heart; it can slow down or pool in…
- Ages
- 18+
- Sex
- All
- Enrolling
- 2,628
- Ends
- Mar 2029
Atrial Fibrillation
REGN7508
This study is researching experimental drugs called REGN7508 and REGN9933. The study is focused on participants who have atrial fibrillation, which means that the heart beats too fast and unevenly. REGN7508 and REGN9933 are designed to help stop blood clots forming in patients with atrial fibrillation. The aim of the…
- Ages
- 18+
- Sex
- All
- Enrolling
- 1,200
- Ends
- Feb 2027
Symptomatic Venous Thromboembolism
REGN7508
This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called Acetylsalicylic Acid (ASA). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement surgery. The aim of the study is to see how effective…
- Ages
- 18+
- Sex
- All
- Enrolling
- 2,000
- Ends
- May 2027
Venous Thromboembolism
REGN7508
This study is researching an experimental drug called REGN7508 (called "study drug"). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement surgery. The aim of the study is to see how effective the study drug is at preventing Venous Thromboembolism (VTE) and other related…
- Ages
- 18+
- Sex
- All
- Enrolling
- 2,000
- Ends
- Feb 2027
Atrial Fibrillation
REGN7508
This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called apixaban. The study is focused on people who have atrial fibrillation, which means that the heart beats too fast and unevenly. The aim of the study is to see how safe and effective…
- Ages
- 18+
- Sex
- All
- Enrolling
- 15,364
- Ends
- Sep 2029
Venous Thromboembolism
REGN7508
This study is researching an experimental drug called REGN7508 (called "study drug") and will consist of 2 parts: Part 1 and Part 2. The study is focused on participants with or without cancer who develop blood clots in certain veins (called Deep Vein Thrombosis \[DVT\]) that block blood flow (Part 1) or focused on…
- Ages
- 18+
- Sex
- All
- Enrolling
- 1,600
- Ends
- Jul 2031
No candidates in your panel· 7
Open trials where none of your patients pre-screened as a candidate or for chart review, or that haven't been pre-screened yet.
Paroxysmal Nocturnal Hemoglobinuria
ALN-CFB
This study is researching an experimental drug called ALN-CFB. The study is focused on people with Paroxysmal Nocturnal Hemoglobinuria (PNH) who are currently taking a complement component C5 inhibitor ("C5-inhibitor") and continue to have anemia (low red blood cell count). The aim of the study is to see how tolerable…
- Ages
- 18+
- Sex
- All
- Enrolling
- 24
- Ends
- Nov 2029
Paroxysmal Nocturnal Hemoglobinuria
Pozelimab
This study is researching an experimental treatment combination with two experimental drugs called pozelimab and cemdisiran. The study is focused on people with paroxysmal nocturnal hemoglobinuria (PNH). The aim of this study is to see how safe and effective the pozelimab + cemdisiran combination is for people with…
- Ages
- 18+
- Sex
- All
- Enrolling
- 202
- Ends
- Oct 2028
Paroxysmal Nocturnal Hemoglobinuria
Pozelimab
This study is researching a treatment combination with two experimental drugs called pozelimab and cemdisiran referred to as "study drugs". Researchers are looking for a better way to treat Paroxysmal Nocturnal Hemoglobinuria (PNH). The aim of the study is to see how well the pozelimab and cemdisiran combination works…
- Ages
- 18+
- Sex
- All
- Enrolling
- 35
- Ends
- Jan 2030
Hemophilia B
REGV131
Participants in this study have a genetic mutation, specifically in the coagulation (blood clotting) Factor 9 gene that causes severe or moderately severe hemophilia B. This study is researching an experimental gene insertion therapy (the adding of a gene into your DNA) called REGV131-LNP1265, also called the "study…
- Ages
- 2+
- Sex
- Male
- Enrolling
- 130
- Ends
- Aug 2034
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
NTLA-2001
To evaluate the efficacy and safety of a single dose of NTLA-2001 compared to placebo in participants with ATTR-CM.
- Ages
- 18–90
- Sex
- All
- Enrolling
- 1,200
- Ends
- Dec 2027
Peripheral Artery Disease
REGN7508
This study is researching 2 different experimental drugs called REGN7508 and REGN9933. The study is focused on people who have Peripheral Artery Disease (PAD), which means that the blood vessels in their arms and legs have become too narrow. People with PAD have a higher risk of getting blood clots after procedures…
- Ages
- 18+
- Sex
- All
- Enrolling
- 7,050
- Ends
- Aug 2029
Venous Thromboembolism
REGN7508
This study is researching 2 different experimental drugs called REGN7508 and REGN9933 (called "study drugs"). The study is focused on people who have a tube placed in a vein to receive treatment (called Peripherally Inserted Central Catheter \[PICC\]). Patients with PICCs have a higher risk of getting blood clots…
- Ages
- 15+
- Sex
- All
- Enrolling
- 1,908
- Ends
- Jun 2029